SB-773812 Uses, Dosage, Side Effects and more
SB-773812 is under investigation in clinical trial NCT00259870 (SB-773812 Administered in Adults With Schizophrenia).
| Trade Name | SB-773812 |
| Generic | SB-773812 |
| Type | |
| Formula | C25H26ClNO4S |
| Weight | Average: 472.0 Monoisotopic: 471.1271072 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
